Cytosorbents Corp expected to post a loss of 7 cents a share - Earnings Preview

Cytosorbents

12/05/2025 21:42

Cytosorbents Corp CTSO.OQ CTSO.O is expected to show a fall in quarterly revenue when it reports  results on May 14 for the period ending March 31 2025

The Princeton New Jersey-based  company is expected to report a 8.0% decrease in revenue to $9.007 million from $9.79 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Cytosorbents Corp is for a loss of 7 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Cytosorbents Corp is $7.00​, above​ its last closing price of $0.87. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.06
-0.06
-0.14
Missed
-121.1
Sep. 30 2024
-0.06
-0.06
-0.04
Beat
36.8
Jun. 30 2024
-0.09
-0.10
-0.08
Beat
17.9​
Mar. 31 2024
-0.12
-0.12
-0.12
Met
0
​​Dec. 31 2023
-0.10
-0.14
-0.13
Beat
5.5
Sep. 30 2023
-0.15
-0.14
-0.21
Missed
-52.2​
Jun. 30 2023
-0.11
-0.11
-0.14
Missed
-24.4
Mar. 31 2023
-0.13
-0.13
-0.17
Missed
-34.2

This summary was machine generated May 12 at 20:42 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)